论文部分内容阅读
观察到单用康赛宁皮下、瘤内注射治疗恶性肿瘤65例,缓解率23.26％;治疗恶性浆膜腔积液22例,有效率95.45％,这些病人的细胞免疫功能也得到加强。
It was observed that only 65 cases of malignant tumors were treated with ketase alone underwent intratumoral injection, with a response rate of 23.26%. 22 cases of malignant serous effusion were treated with 95.45% efficiency. The cellular immune function of these patients was also strengthened.